Impact of dramatic weight loss with the new injectable medications on reproduction in healthy non–polycystic ovary syndrome obese women

Impact of dramatic weight loss with the new injectable medications on reproduction in healthy non–polycystic ovary syndrome obese women

The intake of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) in obese women with polycystic ovary syndrome (PCOS) demonstrated improvement in metabolic and reproductive symptoms; however, their impact in non-PCOS state is unclear. This review critically analyzes data pertaining to GLP-1 RAs...

Full description

Saved in:
Bibliographic Details
Main Author: Zaher Merhi, M.D., H.C.L.D.
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:F&S Reports
Subjects:
GLP-1
PCOS
obesity
reproduction
ovaries
Online Access:http://www.sciencedirect.com/science/article/pii/S2666334124001466
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items